Caissa Capital Management ltd. - Apr 25, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
Apr 25, 2023
Transactions value $
$22,423
Form type
4
Date filed
4/27/2023, 04:07 PM
Previous filing
Apr 24, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $16.7K +5.57K +0.43% $3.00* 1.32M Apr 25, 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $1.26K +425 +0.03% $2.97* 1.32M Apr 26, 2023 See Footnote (1) F1
transaction AVTX Common Stock Purchase $4.45K +1.5K +0.11% $2.96* 1.32M Apr 27, 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182K Apr 25, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.97 to $3.05, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.95 to $2.97, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.